Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tandem Mass Spectrometry | 11 | 2024 | 230 | 3.510 |
Why?
|
| Chromatography, Liquid | 6 | 2023 | 173 | 1.180 |
Why?
|
| Nanoparticles | 3 | 2022 | 449 | 1.060 |
Why?
|
| Rats | 17 | 2024 | 3701 | 1.040 |
Why?
|
| Chromatography, High Pressure Liquid | 7 | 2024 | 458 | 0.920 |
Why?
|
| Reproducibility of Results | 9 | 2024 | 1058 | 0.900 |
Why?
|
| Griseofulvin | 1 | 2024 | 4 | 0.870 |
Why?
|
| Nanomedicine | 3 | 2021 | 52 | 0.870 |
Why?
|
| Mycophenolic Acid | 2 | 2025 | 17 | 0.860 |
Why?
|
| Copper Radioisotopes | 3 | 2012 | 9 | 0.800 |
Why?
|
| Gold | 6 | 2012 | 153 | 0.770 |
Why?
|
| Antineoplastic Agents | 3 | 2022 | 979 | 0.740 |
Why?
|
| Plasma | 1 | 2022 | 38 | 0.730 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2012 | 187 | 0.680 |
Why?
|
| Animals | 26 | 2025 | 16695 | 0.670 |
Why?
|
| Aminopyridines | 1 | 2020 | 26 | 0.660 |
Why?
|
| Oxyquinoline | 1 | 2020 | 6 | 0.660 |
Why?
|
| Tongue | 1 | 2019 | 14 | 0.640 |
Why?
|
| Communicable Diseases | 1 | 2020 | 47 | 0.620 |
Why?
|
| Chloroquinolinols | 1 | 2018 | 4 | 0.590 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2024 | 1737 | 0.590 |
Why?
|
| Tissue Distribution | 5 | 2020 | 230 | 0.560 |
Why?
|
| Enzyme Inhibitors | 1 | 2020 | 457 | 0.550 |
Why?
|
| Anilides | 2 | 2017 | 28 | 0.480 |
Why?
|
| Cyclohexanes | 2 | 2017 | 30 | 0.480 |
Why?
|
| Nanoshells | 2 | 2012 | 2 | 0.470 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2014 | 93 | 0.460 |
Why?
|
| Itraconazole | 1 | 2013 | 13 | 0.420 |
Why?
|
| Nanospheres | 1 | 2013 | 7 | 0.420 |
Why?
|
| Polyglycolic Acid | 1 | 2013 | 48 | 0.410 |
Why?
|
| Positron-Emission Tomography | 2 | 2012 | 93 | 0.400 |
Why?
|
| Microsomes, Liver | 2 | 2024 | 71 | 0.400 |
Why?
|
| Head and Neck Neoplasms | 2 | 2012 | 81 | 0.400 |
Why?
|
| Lactic Acid | 1 | 2013 | 110 | 0.400 |
Why?
|
| Chromans | 1 | 2012 | 14 | 0.380 |
Why?
|
| Drug Carriers | 1 | 2013 | 169 | 0.370 |
Why?
|
| Linear Models | 3 | 2019 | 311 | 0.370 |
Why?
|
| Antifungal Agents | 1 | 2013 | 169 | 0.370 |
Why?
|
| Vitamin E | 1 | 2012 | 56 | 0.370 |
Why?
|
| Neoplasms | 1 | 2022 | 1341 | 0.350 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2011 | 17 | 0.340 |
Why?
|
| Peptides, Cyclic | 1 | 2011 | 29 | 0.340 |
Why?
|
| Glucuronides | 3 | 2025 | 23 | 0.330 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 62 | 0.320 |
Why?
|
| Drug Delivery Systems | 2 | 2022 | 273 | 0.310 |
Why?
|
| Protein Binding | 4 | 2024 | 1076 | 0.300 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 1554 | 0.300 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2024 | 140 | 0.290 |
Why?
|
| Nanotechnology | 4 | 2005 | 176 | 0.290 |
Why?
|
| Male | 11 | 2024 | 22779 | 0.280 |
Why?
|
| Gold Colloid | 3 | 2005 | 5 | 0.280 |
Why?
|
| Sensitivity and Specificity | 3 | 2023 | 602 | 0.270 |
Why?
|
| Rats, Nude | 3 | 2012 | 6 | 0.270 |
Why?
|
| Scattering, Radiation | 1 | 2007 | 43 | 0.260 |
Why?
|
| Metal Nanoparticles | 1 | 2010 | 227 | 0.260 |
Why?
|
| Peptides | 3 | 2005 | 357 | 0.260 |
Why?
|
| Cell Line, Tumor | 6 | 2017 | 2598 | 0.250 |
Why?
|
| Mice | 7 | 2024 | 6490 | 0.250 |
Why?
|
| Light | 1 | 2007 | 182 | 0.250 |
Why?
|
| Drug Stability | 2 | 2018 | 127 | 0.230 |
Why?
|
| Diclofenac | 1 | 2024 | 5 | 0.230 |
Why?
|
| Glycosides | 1 | 2024 | 22 | 0.220 |
Why?
|
| Immunosuppressive Agents | 1 | 2025 | 94 | 0.220 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2017 | 339 | 0.210 |
Why?
|
| Species Specificity | 1 | 2024 | 279 | 0.210 |
Why?
|
| 2,2'-Dipyridyl | 1 | 2003 | 5 | 0.210 |
Why?
|
| Injections, Intralesional | 2 | 2014 | 11 | 0.210 |
Why?
|
| Phenols | 1 | 2024 | 102 | 0.200 |
Why?
|
| Solubility | 2 | 2021 | 134 | 0.200 |
Why?
|
| Humans | 15 | 2025 | 42163 | 0.200 |
Why?
|
| Biological Availability | 2 | 2021 | 115 | 0.200 |
Why?
|
| Injections, Intravenous | 2 | 2013 | 65 | 0.190 |
Why?
|
| Molecular Structure | 2 | 2024 | 560 | 0.190 |
Why?
|
| Doxorubicin | 1 | 2022 | 95 | 0.180 |
Why?
|
| Kidney | 2 | 2024 | 363 | 0.180 |
Why?
|
| Liposomes | 1 | 2022 | 130 | 0.180 |
Why?
|
| Hydrazones | 1 | 2020 | 11 | 0.170 |
Why?
|
| Transplantation, Heterologous | 2 | 2011 | 98 | 0.170 |
Why?
|
| Feasibility Studies | 2 | 2012 | 238 | 0.160 |
Why?
|
| Chemistry, Physical | 1 | 2020 | 50 | 0.160 |
Why?
|
| Macaca fascicularis | 1 | 2020 | 64 | 0.160 |
Why?
|
| Thermodynamics | 1 | 2020 | 226 | 0.150 |
Why?
|
| Neutron Activation Analysis | 2 | 2010 | 2 | 0.150 |
Why?
|
| Heart | 1 | 2020 | 181 | 0.140 |
Why?
|
| Mice, SCID | 2 | 2017 | 158 | 0.140 |
Why?
|
| Serum Albumin, Bovine | 4 | 2004 | 49 | 0.130 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2017 | 28 | 0.130 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2017 | 50 | 0.130 |
Why?
|
| Receptors, Androgen | 1 | 2017 | 144 | 0.120 |
Why?
|
| Particle Size | 3 | 2007 | 267 | 0.120 |
Why?
|
| Cell Nucleus | 3 | 2017 | 383 | 0.120 |
Why?
|
| Pharmaceutical Solutions | 1 | 2014 | 5 | 0.110 |
Why?
|
| Proline | 1 | 2014 | 39 | 0.110 |
Why?
|
| Freeze Drying | 1 | 2013 | 29 | 0.110 |
Why?
|
| Pyrrolidinones | 1 | 2013 | 10 | 0.100 |
Why?
|
| Delayed-Action Preparations | 1 | 2013 | 72 | 0.100 |
Why?
|
| Solvents | 1 | 2013 | 109 | 0.100 |
Why?
|
| Esophageal Neoplasms | 1 | 2014 | 137 | 0.100 |
Why?
|
| Kinetics | 2 | 2024 | 698 | 0.100 |
Why?
|
| Curcumin | 1 | 2013 | 115 | 0.090 |
Why?
|
| Tomography, Emission-Computed | 1 | 2011 | 13 | 0.090 |
Why?
|
| Laser Therapy | 1 | 2011 | 25 | 0.090 |
Why?
|
| Hyperthermia, Induced | 1 | 2011 | 27 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 246 | 0.080 |
Why?
|
| Models, Animal | 1 | 2011 | 149 | 0.080 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 129 | 0.080 |
Why?
|
| Hot Temperature | 1 | 2011 | 141 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2014 | 1586 | 0.080 |
Why?
|
| Mice, Nude | 1 | 2011 | 403 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 456 | 0.080 |
Why?
|
| Octoxynol | 1 | 2007 | 19 | 0.070 |
Why?
|
| Spectrophotometry | 2 | 2004 | 63 | 0.070 |
Why?
|
| Calibration | 1 | 2007 | 62 | 0.070 |
Why?
|
| Cattle | 2 | 2004 | 505 | 0.060 |
Why?
|
| Drug Monitoring | 1 | 2025 | 20 | 0.060 |
Why?
|
| Monosaccharides | 1 | 2024 | 13 | 0.050 |
Why?
|
| Nuclear Localization Signals | 1 | 2004 | 14 | 0.050 |
Why?
|
| Dogs | 1 | 2024 | 201 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2003 | 1188 | 0.050 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2003 | 3 | 0.050 |
Why?
|
| Fluorescamine | 1 | 2003 | 3 | 0.050 |
Why?
|
| Flocculation | 1 | 2003 | 6 | 0.050 |
Why?
|
| Succinimides | 1 | 2003 | 9 | 0.050 |
Why?
|
| Rhodamines | 1 | 2003 | 23 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2003 | 107 | 0.050 |
Why?
|
| Coordination Complexes | 1 | 2003 | 28 | 0.050 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2003 | 103 | 0.050 |
Why?
|
| Sulfhydryl Compounds | 1 | 2003 | 49 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2024 | 147 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 184 | 0.050 |
Why?
|
| Glutathione | 1 | 2003 | 170 | 0.050 |
Why?
|
| Nanostructures | 1 | 2005 | 158 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2003 | 108 | 0.050 |
Why?
|
| Microsomes | 1 | 2022 | 55 | 0.050 |
Why?
|
| Ligands | 1 | 2003 | 387 | 0.050 |
Why?
|
| Glucuronidase | 1 | 2022 | 21 | 0.050 |
Why?
|
| Liver | 1 | 2024 | 503 | 0.040 |
Why?
|
| Protein Transport | 2 | 2017 | 295 | 0.040 |
Why?
|
| Electron Transport | 1 | 2001 | 45 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 2001 | 130 | 0.040 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2017 | 12 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 188 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 173 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 228 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 928 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 774 | 0.030 |
Why?
|
| Polysorbates | 1 | 2013 | 10 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2013 | 21 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 254 | 0.030 |
Why?
|
| Hela Cells | 2 | 2005 | 370 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2013 | 101 | 0.020 |
Why?
|
| Female | 2 | 2014 | 24018 | 0.020 |
Why?
|
| Ethanol | 1 | 2013 | 221 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 933 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 428 | 0.020 |
Why?
|
| Polylysine | 1 | 2004 | 9 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 21 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2004 | 61 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2004 | 27 | 0.010 |
Why?
|
| Gene Products, tat | 1 | 2004 | 36 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 95 | 0.010 |
Why?
|
| Axons | 1 | 2004 | 116 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 314 | 0.010 |
Why?
|
| Metals | 1 | 2004 | 113 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 427 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 314 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 506 | 0.010 |
Why?
|
| Enzymes, Immobilized | 1 | 2001 | 13 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2001 | 33 | 0.010 |
Why?
|
| Hippocampus | 1 | 2004 | 591 | 0.010 |
Why?
|
| Catalase | 1 | 2001 | 111 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 1559 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2004 | 1617 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 11819 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 13458 | 0.010 |
Why?
|
| Neurons | 1 | 2004 | 1246 | 0.010 |
Why?
|